Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 cyclopia sequence 7 Neoplasms 6 Prostatic Neoplasms 5 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Polycystic Ovary Syndrome 3 Pain 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Fatigue 3 Vomiting 2 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Neoplasms, Plasma Cell 2 Nausea 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leiomyoma 2 Hematologic Diseases 2 Head and Neck Neoplasms 2 Burkitt Lymphoma 2 Weight Loss 1 Warts 1 Vitamin D Deficiency 1 Tobacco Use Cessation 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Exercise 6 Transcranial Direct Current Stimulation 4 Neuropsychological Tests 4 Memantine 3 Walking 2 Standard of Care 2 Patient Reported Outcome Measures 2 Methods 2 Electroencephalography 2 Drug Therapy 2 Donepezil 2 Cognitive Behavioral Therapy 2 mazdutide 1 lithium sulfate 1 lime 1 enzalutamide 1 beta Carotene 1 acetaminophen, aspirin, caffeine drug combination 1 XENP 1595 1 Vitamin E 1 Vitamin D 1 Ultraviolet Therapy 1 Time 1 Tai Ji 1 Tablets 1 Surveys and Questionnaires 1 Sugars 1 Sodium Chloride 1 Sirolimus 1 Riluzole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed

276 enrolled 33 charts

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡